Clinical Trial Update: Disulfiram in Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a completed Phase 1/2 clinical trial evaluating disulfiram in patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Disulfiram (Disulfiram)

Snippet

Sponsor: John P. Fruehauf | Conditions: Stage IV Melanoma | Phase 1, Phase 2 | Status: COMPLETED